NKTR Historical PE Ratio image   This NKTR PE ratio history page last updated 8/8/2022
NKTR Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/4/2022
4.42-0.85-3.40NA
Q1 2022
5/5/2022
4.44-0.49-1.96NA
Q4 2021
2/28/2022
10.24-0.79-3.16NA
Q3 2021
11/4/2021
16.65-0.70-2.80NA
Q2 2021
8/5/2021
15.87-0.69-2.76NA
Q1 2021
5/6/2021
18.52-0.68-2.72NA
Q4 2020
2/25/2021
22.44-0.65-2.60NA
Q3 2020
11/5/2020
16.89-0.61-2.44NA
Q2 2020
8/6/2020
21.51-0.45-1.80NA
Q1 2020
5/7/2020
19.88-0.53-2.12NA
Q4 2019
2/27/2020
20.53-0.64-2.56NA
Q3 2019
11/6/2019
18.10-0.56-2.24NA
Q2 2019
8/8/2019
29.57-0.63-2.52NA
Q1 2019
5/8/2019
32.98-0.68-2.72NA
Q4 2018
2/28/2019
40.54-0.57-2.28NA
Q3 2018
11/7/2018
37.95-0.56-2.24NA
Q2 2018
8/8/2018
55.965.3321.322.6
Q1 2018
5/10/2018
77.29-0.60-2.40NA
Q4 2017
3/1/2018
84.55-0.11-0.44NA
Q3 2017
11/7/2017
26.840.371.4818.1
Q2 2017
8/8/2017
19.64-0.39-1.56NA
Q1 2017
5/9/2017
17.54-0.42-1.68NA
Q4 2016
3/1/2017
13.01-0.28-1.12NA
Q3 2016
11/3/2016
11.85-0.32-1.28NA
Q2 2016
8/3/2016
17.53-0.36-1.44NA
Q1 2016
5/3/2016
15.59-0.14-0.56NA
Q4 2015
3/1/2016
11.47-0.40-1.60NA
Q3 2015
11/5/2015
12.30-0.06-0.24NA
Q2 2015
8/5/2015
12.30-0.40-1.60NA
Q1 2015
4/30/2015
9.520.251.009.5
Q4 2014
2/24/2015
13.48-0.35-1.40NA
Q3 2014
11/6/2014
13.560.532.126.4
Q2 2014
7/31/2014
10.55-0.26-1.04NA
Q1 2014
5/7/2014
11.22-0.37-1.48NA
Q4 2013
2/26/2014
13.70-0.41-1.64NA
Q3 2013
11/7/2013
8.96-0.14-0.56NA
Q2 2013
8/8/2013
10.94-0.37-1.48NA
Q1 2013
5/9/2013
9.93-0.48-1.92NA
Q4 2012
2/28/2013
9.27-0.46-1.84NA
Q3 2012
11/9/2012
8.15-0.38-1.52NA
Q2 2012
8/9/2012
8.30-0.30-1.20NA
Q1 2012
5/2/2012
7.61-0.36-1.44NA
NKTR PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/4/2022
4.42-0.85-2.83NA
Q1 2022
5/5/2022
4.44-0.49-2.67NA
Q4 2021
2/28/2022
10.24-0.79-2.86NA
Q3 2021
11/4/2021
16.65-0.70-2.72NA
Q2 2021
8/5/2021
15.87-0.69-2.63NA
Q1 2021
5/6/2021
18.52-0.68-2.39NA
Q4 2020
2/25/2021
22.44-0.65-2.24NA
Q3 2020
11/5/2020
16.89-0.61-2.23NA
Q2 2020
8/6/2020
21.51-0.45-2.18NA
Q1 2020
5/7/2020
19.88-0.53-2.36NA
Q4 2019
2/27/2020
20.53-0.64-2.51NA
Q3 2019
11/6/2019
18.10-0.56-2.44NA
Q2 2019
8/8/2019
29.57-0.63-2.44NA
Q1 2019
5/8/2019
32.98-0.683.529.4
Q4 2018
2/28/2019
40.54-0.573.6011.3
Q3 2018
11/7/2018
37.95-0.564.069.3
Q2 2018
8/8/2018
55.965.334.9911.2
Q1 2018
5/10/2018
77.29-0.60-0.73NA
Q4 2017
3/1/2018
84.55-0.11-0.55NA
Q3 2017
11/7/2017
26.840.37-0.72NA
Q2 2017
8/8/2017
19.64-0.39-1.41NA
Q1 2017
5/9/2017
17.54-0.42-1.38NA
Q4 2016
3/1/2017
13.01-0.28-1.10NA
Q3 2016
11/3/2016
11.85-0.32-1.22NA
Q2 2016
8/3/2016
17.53-0.36-0.96NA
Q1 2016
5/3/2016
15.59-0.14-1.00NA
Q4 2015
3/1/2016
11.47-0.40-0.61NA
Q3 2015
11/5/2015
12.30-0.06-0.56NA
Q2 2015
8/5/2015
12.30-0.400.03410.0
Q1 2015
4/30/2015
9.520.250.1756.0
Q4 2014
2/24/2015
13.48-0.35-0.45NA
Q3 2014
11/6/2014
13.560.53-0.51NA
Q2 2014
7/31/2014
10.55-0.26-1.18NA
Q1 2014
5/7/2014
11.22-0.37-1.29NA
Q4 2013
2/26/2014
13.70-0.41-1.40NA
Q3 2013
11/7/2013
8.96-0.14-1.45NA
Q2 2013
8/8/2013
10.94-0.37-1.69NA
Q1 2013
5/9/2013
9.93-0.48-1.62NA
Q4 2012
2/28/2013
9.27-0.46-1.50NA
Q3 2012
11/9/2012
8.15-0.38NANA
Q2 2012
8/9/2012
8.30-0.30NANA
Q1 2012
5/2/2012
7.61-0.36NANA
Quotes delayed 20 minutes

Email EnvelopeFree NKTR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Nektar Therapeutics (NKTR) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

NKTX PE Ratio History
NLTX PE Ratio History
NMTC PE Ratio History
NMTR PE Ratio History
NOTV PE Ratio History
NOVN PE Ratio History
NPCE PE Ratio History
NRBO PE Ratio History
NRC PE Ratio History
NRIX PE Ratio History
How should the NKTR historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Nektar Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this NKTR Historical PE Ratio page.

What is the average historical PE for NKTR based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The NKTR historical PE ratio using the annualized quarterly earnings method works out to 9.2.

What is the average historical PE for NKTR based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The NKTR historical PE ratio using the TTM earnings method works out to 84.5.

On this page we presented the NKTR Historical PE Ratio information for Nektar Therapeutics' stock. The average NKTR historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 9.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average NKTR historical PE based on this TTM earnings result method is 84.5. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this NKTR historical PE result, against the recent PE: when this page was posted on 8/5/2022, the most recent closing price for NKTR had been 4.88, and the most recent quarterly earnings result, annualized, was 21.32. Meanwhile, the most recent TTM earnings summed to 3.52. From these numbers, we calculate the recent NKTR PE on 8/5/2022 based on annualized quarterly EPS was 0.2. Based on NKTR's history, that recent PE is low relative to the historical average, with the recent PE 97.8% lower than the historical average PE across our data set for Nektar Therapeutics. Looking at the recent NKTR PE on 8/5/2022 based on TTM EPS, we calculate the ratio at 1.4. Based on NKTR's history, that recent PE is low relative to the historical average, with the recent PE 98.3% lower than the average PE across our Nektar Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on NKTR or any other given stock, valuation analysis for NKTR can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Nektar Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NKTR. Thanks for visiting, and the next time you need to research NKTR Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: SF YTD Return, Funds Holding PSFE, REIS shares outstanding history.

 

NKTR Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.